Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04678232 · ClinicalTrials.gov registry record · NA

Positive Processes and Transition to Health

A NA study, sponsored by Case Western Reserve University.

Completed
Registry status
NA
Development phase
45
Enrollment target

NCT04678232 is a NA study that has completed, run by Case Western Reserve University. The registered enrollment target is 45 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04678232, a NA study, has completed, sponsored by Case Western Reserve University.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target

Study Summary

The R61 will be an open trial to determine if Positive Processes and Transition to Health (PATH) engages the proposed targets: unproductive processing, avoidance, and reward deficits in a sample of 45 adults who have experienced a destabilizing life event involving profound loss or threat, report persistent stressor-related symptoms of PTSD and/or depression, and are elevated on symptoms related to 2 of the 3 therapeutic targets. Additionally, will examine whether patients perceive PATH as helpful and complete/adhere to treatment, and therapist fidelity. Patients will receive 6 sessions of PATH (with 2 boosters, if partial responders). Primary targets will be assessed at pre-treatment, week 4, post-treatment, and at 1- and 3-month follow-up; secondary targets at pre-treatment, weekly during treatment, post-treatment, and at 1- and 3-month follow-ups.

Interventions

  • BEHAVIORAL Positive Processes and Transition to Health (PATH)

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2021-10-01
Est. Completion 2023-06-30
Phase NA

Sponsor

Case Western Reserve University

141 total trials

What the Registry Record Tells You About NCT04678232

The ClinicalTrials.gov registry entry for NCT04678232 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Western Reserve University, which has 141 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Positive Processes and Transition to Health (PATH) is the first listed.

NCT04678232 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04678232 about?

NCT04678232 is a clinical study titled "Positive Processes and Transition to Health". The R61 will be an open trial to determine if Positive Processes and Transition to Health (PATH) engages the proposed targets: unproductive processing, avoidance, and reward deficits in a sample of 45 adults who have experienced a destabilizing life event involving profound loss or threat, report pe...

What is the current status of trial NCT04678232?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2021-10-01. Estimated completion is 2023-06-30.

What interventions are being tested in trial NCT04678232?

The interventions under investigation include: Positive Processes and Transition to Health (PATH) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04678232?

This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.